A pilot study examining energy conservation for cancer treatment-related fatigue

Andrea M. Barsevick, Kyra Whitmer, Carole Sweeney, Lillian M. Nail

    Research output: Contribution to journalArticle

    43 Scopus citations

    Abstract

    The purpose of this pilot study was to examine the feasibility of conducting an energy conservation and activity management (ECAM) intervention for cancer treatment-related fatigue and describe patterns of cancer treatment-related fatigue for two groups undergoing active treatment, one receiving the ECAM intervention and a nonequivalent control group receiving standard care for cancer treatment-related fatigue. The ECAM group received 3 telephone sessions focusing on the provision of information about fatigue, development of an energy conservation plan, and evaluation of the plan's effectiveness. Data for the ECAM group were collected before treatment, at an expected fatigue high point during treatment, and an expected low point of fatigue after treatment. The nonequivalent control group lacked the pretreatment measure but had equivalent follow-up measurement points. The feasibility of conducting the ECAM intervention was supported by patient adherence in receiving all 3 sessions of the intervention and by their self-reports of its usefulness and plans to continue using ECAM skills. Patterns of fatigue differed for the ECAM study group and the nonequivalent control group, suggesting that the intervention moderates the expected rise in fatigue due to cancer therapy. A full-scale clinical trial is needed to evaluate the efficacy of the ECAM intervention.

    Original languageEnglish (US)
    Pages (from-to)333-341
    Number of pages9
    JournalCancer Nursing
    Volume25
    Issue number5
    DOIs
    StatePublished - Oct 2002

    Keywords

    • Cancer treatment-related fatigue
    • Energy conservation

    ASJC Scopus subject areas

    • Oncology
    • Oncology(nursing)

    Fingerprint Dive into the research topics of 'A pilot study examining energy conservation for cancer treatment-related fatigue'. Together they form a unique fingerprint.

  • Cite this